activated charcoal
Sign in to saveAlso known as Activated carbon, Carbon, Activated, Charcoal, Activated, Medicinal carbon
medication used to treat ingested poisonings
Medication
- Generic name
- Aconitum Napellus, Arsenic Trioxide, Atropa Belladonna, Oyster Shell Calcium Carbonate, Crude, Activated Charcoal, Human Breast Tumor Cell, Causticum, Gelsemium Sempervirens Root, Lachesis Muta Venom, Mercury, Sodium Chloride, Nitric Acid, Phosphorus, Toxicodendron Pubescens Leaf
- Brand names
- Anxiety Ii Hp, Actidose, Insta-Char, CharcoCaps
- Drug class
- Charcoal preparations
- Active ingredients
- activated charcoal, activated charcoal / bile salts / pancreatin, activated charcoal / salicylic acid / sulfur, activated charcoal / methenamine, activated charcoal / calcium carbonate, activated charcoal / papaverine
- Route
- Oral
- Dosage form
- Powder for Oral Suspension, Oral Capsule, Oral Suspension, Oral Tablet, Oral Gel
- Type
- Human Otc Drug
- Manufacturer
- Natural Creations, Inc.
Indications: USES: Temporarly relieves simple nervous tension.** (per FDA label)
Sources: openFDA · RxNorm (NLM). Not medical advice.
Clinical Trials
71 registered- PHASE1COMPLETEDA Study on The Effect of Multiple Doses of Activated Charcoal on The Pharmacokinetics of a Single Dose of RO4995819Hoffmann-La Roche · NCT01409369
- PHASE2UNKNOWNRole of Activated Charcoal in Decreasing Blood Urea, Creatinine and PhosphorousAssiut University · NCT04311645
- PHASE1COMPLETEDBioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal BlockIntech Biopharm Ltd. · NCT02466347
- PHASE4COMPLETEDDoes a Soft Drink Mixture Improve Tolerance of Activated Charcoal in the Adult Poisoned Patient Without Affecting EfficacyState University of New York - Upstate Medical University · NCT06219967
- PHASE1COMPLETEDA Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy ParticipantsBristol-Myers Squibb · NCT05320094
- PHASE2COMPLETEDPilot Pharmacokinetic Clenil Study With AeroChamber Plus™ or Volumatic™ Spacer DevicesChiesi Farmaceutici S.p.A. · NCT01370031